Atlas Trials

Reparixin in Pancreatic Islet Transplantation

Clinical trial NCT01220856 · COMPLETED

Trial details

NCT number
NCT01220856
Sponsor
Dompé Farmaceutici S.p.A
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus
Start date
2010-07-28
Primary completion
2013-04-30
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.